Hi everyone-

HNY! Is anyone compounding amoxicillin suspension in-house (inpatient or outpatient)? If so, I would love to get your recipe, etc. Thank you!

Merry Christmas and Happy New Year everyone.

I am the pharmacy director at a rural Critical Access Hospital in Northwest Ohio and am working through the new TJC standard for Antimicrobial Stewardship, MM.09.01.01 that go into effect on 1/1/2023.

I am tempted to ask a broad question about how other hospitals are meeting the new/revised EPs but will keep my questions more focused on the EPs that seem more daunting.

Hello colleagues,

Assuming you have both syringe pump and large volume pump infusion capability, what logic informs the dispensing of your neonatal/pediatric intermittent infusions?

1) Weight-based? (>10 kg, IVPB instead of a syringe)
2) Concentration/max volume-based? (>50 mL of x concentration, IVPB instead of syringe)
3) All non-adult doses administered in a syringe?
4) Other?

Thank you kindly,
Megan Fragale, PharmD, MS, BCPS
Medication Safety Officer
Skagit Regional Health

In a 30 days span we experienced multiple Alaris pump/Alaris tubing issues and wondering if anyone else is experiencing the same issue.

The issues identified were Alaris free flowing medications. This is happening mainly after the initial programming of the infusions. We did through investigation and we excluded user programming errors. We ran diagnostics and the pump doesn't even record it is free flowing. BD so far unable to replicate incidents and unable to find why.

In light of the Smith Medical urgent medical device correction letter (attached), I would like to ask what changes and/or education has your institution implemented?
Thank you,
Amirah A.
HNMC

Dear colleagues
We are currently looking into establishing clinical pharmacy services in pain management, with a focus on elderly patients and discharge preparation.
In Switzerland, experience in this field is very limited.
Would anybody be willing to share concepts or policies with us?
This would be much appreciated.
Thank you very much and happy holidays from Switzerland
Carla

Prof. Dr. phil. II Carla Meyer-Massetti
Assistant professor of clinical pharmacy
University Hospital of Bern, Bern, Switzerland

I have noticed our insulin scanning rate at by behavioral health facility has been falling. We currently use 10 mL vials of insulin detemir and aspart. I am considering a switch to the detemir and aspart pens in hopes of cutting out steps and increasing our BCMA rates.

Has anyone had success making this transition, in behavioral health or acute care? Or, does anyone have success stories of increasing your subQ insulin scanning rates?

Thanks,

Matt Hamrick, PharmD, MS
Director of Pharmacy, SUN Behavioral Columbus

Wondering if/how others store controlled substances in their sterile compounding suites. We are open 24/7 but only have technicians working in that space with the pharmacists being in the main pharmacy. Appreciate others thoughts/insights!

The Yale-New Haven Hospital PGY2 Medication Use Safety and Policy residency program will be hosting a virtual open house on Tuesday, Dec 20th 5-6:30PM EST. Please extend this invitation to PGY1s or other interested staff. A link will be shared directly with interested parties. RSVP to: Julie.Dambrosi@ynhh.org

Reaching out to see if any organization utilizing HelioMetrics Diversion Software would be willing to share their policy and procedures developed for monitoring. Specifically looking into what you are viewing daily, weekly, monthly, quarterly, default settings etc
In addition, any quick wins post go live you would share with others or anything over time that you have decided is not valuable that you have turned off in the system. Thank you in advance.